<DOC>
	<DOC>NCT00058903</DOC>
	<brief_summary>The goal of this study is to find an effective and well-tolerated medical therapy for itching due to liver disease. Persons with primary biliary cirrhosis or chronic hepatitis C are currently being enrolled in the study. Persons participating in the study are given sertraline, a medication which is also often used for depression,to treat their itching. The dose is gradually increased as the effect on itching and any other potential side effects are carefully monitored.</brief_summary>
	<brief_title>Treatment of Cholestatic Pruritus With Sertraline</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Pruritus</mesh_term>
	<mesh_term>Liver Cirrhosis, Biliary</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Itching for at least 3 months Primary biliary cirrhosis or hepatitis C Elevated alkaline phosphatase for at least 6 months</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Cholestatic</keyword>
	<keyword>Pruritus</keyword>
	<keyword>Sertraline</keyword>
	<keyword>primary biliary cirrhosis</keyword>
	<keyword>hepatitis C</keyword>
</DOC>